Immune Checkpoint Inhibitor Related Atherosclerotic Cardiovascular Disease
While immune checkpoint inhibitors have transformed how some malignant tumors are treated in recent years,it has also resulted in the occurrence of unique immune-related adverse events,including the cardiovascular system.Some recent clinical research suggests that immune checkpoint inhibitors may be connected to the onset and progression of atherosclerosis,however many investigations on cardiovascular adverse events due to treatment with immune checkpoint inhibitors are primarily limited to myocarditis.This article reviews the possible pathological mechanism and clinical significance of immune checkpoint inhibitors related atherosclerotic cardiovascular disease,in order to improve clinicians'awareness of atherosclerosis cardiovascular disease and guard against its occurrence.
万方数据
维普
